The Impact of Stress on the Immune System of Cancer Patients in Alahsa, Saudi Arabia
Background: Psychological stress adversely affects immune function, potentially influencing cancer progression and patient outcomes globally. Objective: This study aims to evaluate the impact of stress on the immune system of cancer patients in Al-Ahsa, Saudi Arabia, and its correlation with disease progression and treatment response. Methods: A cross-sectional study was conducted in Al-Ahsa during 2019, enrolling 1,000 cancer patients. Stress levels were assessed using the Perceived Stress Scale (PSS). Immune parameters, including cortisol levels, natural killer (NK) cell activity, and cytokine profiles (e.g., IL-6, TNF-α), were measured through blood samples. Statistical analysis was performed using SPSS version 26.0, employing descriptive statistics, Pearson correlation, and multivariate regression to examine relationships between stress and immune markers. Additionally, Receiver Operating Characteristic (ROC) curve analysis was utilized to determine the predictive accuracy of stress on immune dysfunction and clinical outcomes. Results: High stress levels were reported by 68% of patients. Elevated cortisol was observed in 72% of highly stressed patients compared to 28% in low-stress groups (p < 0.001). NK cell activity was significantly reduced in stressed patients, with a mean decrease of 35% (p < 0.001). IL-6 and TNF-α levels were elevated in 65% and 60% of patients experiencing high stress, respectively (p < 0.001). Multivariate analysis revealed that stress independently predicted reduced NK activity (β = -0.45, p < 0.001) and increased pro-inflammatory cytokines (β = 0.50, p < 0.001). Additionally, stress was associated with a 20% higher rate of disease progression (OR = 1.20, 95% CI: 1.05-1.37) and a 15% poorer treatment response (OR = 0.85, 95% CI: 0.78-0.93). ROC analysis demonstrated that the PSS score had an area under the curve (AUC) of 0.82 (95% CI: 0.78-0.86) for predicting immune dysfunction. The combined effect of high stress and immune dysregulation contributed to a 25% increase in overall mortality risk (p < 0.05). Furthermore, subgroup analysis indicated that females exhibited a higher prevalence of stress-induced immune alterations compared to males (75% vs. 62%, p = 0.004). Conclusions: Stress significantly impairs immune function in cancer patients in Al-Ahsa, Saudi Arabia, correlating with increased disease progression and diminished treatment efficacy. These findings underscore the necessity for integrating stress management interventions in oncology care to enhance patient outcomes.